Drug Makers New Targets for U.S. Fraud Inquiries, Report Says
December 16, 2010
The New York Times
By Duff Wilson
Four pharmaceutical companies paid more than half of the $19.8 billion in civil and criminal settlements the last 20 years for improper billings to federal and state governments, according to a report Thursday by Public Citizen’s Health Research Group.
“Step aside, defense industry, there’s a new defrauder in town,” the group said on its Web site with the release of a 35–page report. Read more